Definium Therapeutics, Inc. (DFTX)
23.48
-0.04
(-0.15%)
USD |
NASDAQ |
May 28, 16:00
23.45
-0.04
(-0.15%)
After-Hours: 18:44
Definium Therapeutics EPS Diluted (Quarterly) : -0.7087 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Atai Beckley, Inc. | -0.0833 |
| Resonate Blends, Inc. | -0.0034 |
| Nutriband, Inc. | -0.0796 |
| Q/C Technologies, Inc. | -0.1896 |
| GH Research Plc | -0.3057 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -77.10M |
| Total Expenses (Quarterly) | 77.10M |
| Enterprise Value | 2.233B |
| Earnings Yield | -10.66% |
| Normalized Earnings Yield | -9.097 |